Results 61 to 70 of about 7,279 (128)

Expression of MUC2 Glycoprotein Antibody and Vascular Endothelial Growth Factor in Barrett’s Mucosa

Acta Clinica Croatica, 2019
Higher expression of the mucin 2 (MUC2) glycoprotein and vascular endothelial growth factor (VEGF) in Barrett’s mucosa may be associated with a higher risk of esophageal adenocarcinoma development.
Melanija Ražov Radas
doaj   +1 more source

Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study

International Journal of General Medicine, 2021
Xin Liu,1,* Qingtao Jiang,2,* Chao Yue,3 Qin Wang2 1Department of Prevention and Control for Occupational Disease, Jiangsu Provincial Center for Disease Control and Prevention & Jiangsu Preventive Medicine Association, Nanjing, People’s Republic ...
Liu X, Jiang Q, Yue C, Wang Q
doaj  

Immunotherapy as a new perspective for the therapy of esophageal cancer

Innovative Surgical Sciences
The therapeutic landscape in nearly every therapeutic line in advanced/metastatic patients with squamous cell carcinoma (SCC) and esophagogastric adenocarcinoma (EGC) is enriched by recent approvals of immune checkpoint inhibitors (ICIs).
Huber Yvonne, Moehler Markus, Högner Anica   +2 more
doaj   +1 more source

PERIOPERATIVE AND COMPLICATION MANAGEMENT FOR ADENOCARCINOMA OF THE ESOPHAGUS AND ESOPHAGOGASTRIC JUNCTION

Медицинский вестник Юга России, 2014
Esophagectomy remains a challenging procedure both for the patient and the surgeon. Patient selection and evaluation aims at preventing individuals unfit for surgery or without chance of cure from this operation.
K. Tobias, E. Beckurts
doaj   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Case Report: Intraoperative endoscopic treatment for the “pseudo” lumen formation of jejuno-esophageal anastomosis in laparoscopic total gastrectomy

Frontiers in Oncology
Recently, the incidence of adenocarcinoma of esophagogastric junction (AEG) is increasing in China. Laparoscopic total gastrectomy plus D2 lymph node dissection is an important treatment method for AEG of Siewert type II.
Zhixiong Chen, Xiaojie Gao, Jingkun Shang, Jieli Huang, Shouru Zhang   +4 more
doaj   +1 more source

Risk factors associated with early recurrence of adenocarcinoma of esophagogastric junction (typeⅠ, Ⅱ) after radical resection

Zhongguo aizheng zazhi, 2016
Background and purpose: Adenocarcinoma of the esophagogastric junction (AEG) has a high incidence of early recurrence and metastasis after operation. The prognosis of AEG is poor. However, few studies have investigated the recurrence of AEG.
黄永高, 王鹏程, 王　嵩
doaj  

Clinical characteristics and prognostic outcomes for adenocarcinoma of esophagogastric junction in early-onset patients: a population-based appraisal. [PDF]

J Cancer Res Clin Oncol, 2023
Lai H, Zheng J, Zhou G, Li Y.
europepmc   +1 more source

Utility of robotic surgery for Siewert type II/III adenocarcinoma of esophagogastric junction: transhiatal robotic versus laparoscopic approach. [PDF]

BMC Surg, 2023
Nishi M, Wada Y, Yoshikawa K, Takasu C, Tokunaga T, Nakao T, Kashihara H, Yoshimoto T, Shimada M.   +8 more
europepmc   +1 more source

Efficacy analysis of Cheng's GIRAFFE reconstruction after proximal gastrectomy for adenocarcinoma of esophagogastric junction. [PDF]

Chin J Cancer Res, 2022
Xu Z, Hu C, Zhang Y, Huang L, Yang L, Yu J, Yu P, Chen J, Du Y, Cheng X.   +9 more
europepmc   +1 more source